The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
FVR C-P (Canada)This page contains information on FVR C-P for veterinary use.
The information provided typically includes the following:
- FVR C-P Indications
- Warnings and cautions for FVR C-P
- Direction and dosage information for FVR C-P
Fvr C-pThis treatment applies to the following species:
Feline Rhinotracheitis-calici-panleukopenia Vaccine
MODIFIED LIVE AND KILLED VIRUS
For veterinary use in cats only
FVR® C-P vaccine is a combination of antigens for convenient use in healthy cats 8 to 9 weeks of age or older as an aid in the prevention of disease caused by feline rhinotracheitis, feline calici and feline panleukopenia viruses. The feline rhinotracheitis-calici component is a lyophilized suspension of modified live viruses propagated in a stable cell line of feline origin and backfilled with an inert gas. The feline panleukopenia virus is propagated in a stable cell line of feline origin. The virus has been chemically inactivated and determined to be non-viricidal when used as a diluent to rehydrate the feline rhinotracheitis-calici vaccine. The safety and efficacy of each virus strain has been demonstrated by vaccination and challenge tests in healthy susceptible cats.
FVR C-P Dosage And Administration
Transfer contents of the PANAGEN® vaccine vial to the FVR® C vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.
Prior To Use, Warm The Panagen® Vaccine To Room Temperature And Shake Well.
Two doses are required for primary immunization.
Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 8 to 9 weeks of age or older.
Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination.
If the animal is less than 12 weeks of age, it should be revaccinated every 3 to 4 weeks until 12 to 16 weeks of age.
Annual revaccination with one dose is recommended.
- Store at 2°- 7°C.
- Do not freeze.
- Do not mix with other vaccines.
- Use new, non-chemically sterilized needles and syringes.
- Burn vaccine container and all unused contents.
- Contains gentamicin and amphotericin B as preservatives.
- Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.
- Do not vaccinate pregnant cats.
- The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions.
AntidoteEpinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
U.S. Veterinary License No. 165A
Intervet Inc., Millsboro, Delaware 19966 USA
Intervet Canada Corp., 16750, route Transcanadienne, Kirkland QC, H9H 4M7
For technical enquiries, call toll free 1 888 306-0069.
® Registered trademark of Schering-Plough Animal Health Corporation, used under license by Intervet Canada Corp.
Intervet Canada Corp.
16750 ROUTE TRANSCANADIENNE, KIRKLAND, QC, H9H 4M7
|Fax:||Toll-free 888-498-4444; local 514-428-7014|
|Every effort has been made to ensure the accuracy of the FVR C-P information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-01-04